Lexaria Bioscience Corp. (LEXX)
0.7588
+0.03
(+3.82%)
USD |
NASDAQ |
Jan 16, 16:00
0.7437
-0.02
(-1.99%)
After-Hours: 20:00
Lexaria Bioscience Total Liabilities (Quarterly): 1.527M for Nov. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | 10.74M |
| Aurinia Pharmaceuticals, Inc. | 161.76M |
| Edesa Biotech, Inc. | 1.210M |
| Xenon Pharmaceuticals, Inc. | 48.32M |
| ProMIS Neurosciences, Inc. | 12.27M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.051M |
| Shareholders Equity (Quarterly) | 4.913M |
| Debt to Equity Ratio | 0.0207 |
| Current Ratio | 3.682 |
| Net Debt Paydown Yield | 0.03% |